Local management with methotrexate of cesarean scar ectopic pregnancy with live embryo guided by transvaginal ultrasound: A case report

Abstract

Cesarean scar ectopic pregnancy is a rare type of ectopic pregnancy with high morbidity and mortality. Use of conservative conducts, including medical management with methotrexate, has avoided mutilating surgeries such as hysterectomy and spared the fertility of women. We report the case of a 30-year old patient with a cesarean scar ectopic pregnancy, with a live embryo, who was treated locally with transvaginal ultrasound-guided injection of methotrexate, complemented with various doses of systemic methotrexate.

Scar Ectopic Pregnancy as an Uncommon Site of Ectopic Pregnancy: A Case Report and Literature Review

“…Based on the extracted data of the included studies [1,25,[37][38][39][40][41], the diagnosis of scar ectopic pregnancy was confirmed using various diagnostic methods, such as a transvaginal ultrasound, MRI, and transvaginal ultrasound-guided puncture. The patients presented with symptoms such as abdominal pain, vaginal bleeding, and spotting.…”

Introductory Chapter: An Overview of the Diagnosis and Treatment of Non-tubal Ectopic Pregnancy

“…In cesarean scar pregnancy when the embryo/fetus has heartbeat, local methotrexate (1 mg/kg) treatment guided by transvaginal ultrasound should be the first option [23] (Figures 8 and 9). The current scientific evidences demonstrate that local treatment with MTX brings best results.…”